Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AOP Orphan Pharmaceuticals AG
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1\. Patients previously participating in the randomized TripleTRE trial who are able and willing to provide a signed informed consent for study participation in NIS
You may not be if
1. Lost to follow-up patients of TripleTRE study
2. Patients who discontinued all medicinal PAH treatments (e.g. after successful lung transplantation)
3. Patients who withdrew from the initial TripleTRE trial due to significant non-compliance with trial requirements (not adhering to therapy, not coming to hospital visits)
Clareo Health | A Prospective Non-interventional Observational Study to Observe Long-term Treatment and Outcomes in Pulmonary Arterial Hypertension (PAH) Patients
